CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to revolutionize the treatment of aortic aneurysms by developing bioresorbable endografts that deliver therapeutic drugs. Utilizing 3D bioprinting and advanced modeling, it focuses on early healing rather than late-stage intervention, addressing critical challenges in safety, drug delivery, and healin…
Forty years ago, the endograft (EG) enabled the endovascular treatment of aortic aneurysm (AoA) and revolutionized vascular surgery.
Still, since then, its technological concept has remained substantially unchanged:
EG is a passive device aimed at treating the AoA in its late stage, not to cure the disease, even when discovered early.
This proposal introduces a bio-engineered process to redesign EGs as 3D bio-printed, bioresorbable devices loaded with active drug components and validated in-vitr…
UNIVERSITA DEGLI STUDI DI PAVIA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
